Trial intelligence / Profile preview

Pharmacokinetics of Mycophenolate Mofetil in Lung Transplant Recipients

NCT01014442Phase 3Completed

Sponsor
Roche
Start
Jan 2010
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mycophenolate mofetil in lung transplant rejection, sponsored by Roche. Started Jan 2010; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

lung transplant rejection

Beyond the preview

Go deeper on NCT01014442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01014442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call